Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Imperial receives Gates Foundation grant to develop new tests for managing AIDS treatment in developing countries

22.11.2005


Imperial College London has received a £4.9 ($8.6) million grant from the Bill & Melinda Gates Foundation to develop a simple, affordable and rapid test to measure the health of the immune system in HIV/AIDS patients in developing countries.



The ‘CD4 Initiative’ will develop an easy to use device which can measure CD4+ T-lymphocytes in HIV+ patients. The CD4 cell count measures the number of these critical disease-fighting cells in the blood, a figure which health care workers need in order to make key clinical decisions in managing HIV disease, such as when to begin or to switch antiretroviral therapy.

Current technologies for measuring CD4 counts are expensive to buy and maintain, and require a level of infrastructure and training which is often not available in many developing countries. The CD4 Initiative will develop new tests that are more appropriate for these countries based on specifications developed with health care workers in hospitals and clinics in Africa and elsewhere in the developing world.


Professor Stephen Smith, Principal of the Faculty of Medicine at Imperial College London, said: “Despite the burden of HIV/AIDS on the developing world, many of the diagnostic tools are just not accessible there due to the high cost and complexity of use. This initiative will help develop new, simple, rapid, robust and affordable tools and help remove one important barrier to the effective implementation of AIDS care in these countries.”

The principal investigator, Dr. Hans George Batz, together with the Imperial-based team will manage an R&D programme to develop these much needed diagnostics. Dr. Batz is a former Senior Vice President of Research and Development at Roche Diagnostics and has been involved with the development of the initiative for the past two years. Dr. Batz will be supported by an international steering committee of experts, a small staff and the Imperial College’s liaison to the project, Dr. Wendy Ewart. The initiative will take a project management approach, common in industry, in which multiple research teams around the world from academia, private companies and other institutions will work collaboratively under the leadership of Dr. Batz and with strict milestones and timelines to achieve.

A Research Funding Agreement for interested test developers and researchers for the CD4 Initiative will be issued in spring 2006. Inquiries about the project can be made to cd4@icl.ac.uk.

Gregg Gonsalves, from Gay Men’s Health Crisis in New York City, and who was instrumental in the establishment of the initiative, praised the Bill & Melinda Gates Foundation and Imperial College: “The CD4 Initiative is providing a bold new solution to this key problem in public health by bringing together the know-how in product development from industry with the creativity of scientists from all quarters to bring a product to the field more quickly than could be done otherwise. Healthcare workers from developing countries have been clamouring for point-of-care assays for measuring CD4 counts for several years now as management of antiretroviral therapy is difficult without these tests. We are elated that Dr. Batz, Imperial College and the Bill & Melinda Gates Foundation are responding to these urgent pleas for help.”

Tony Stephenson | alfa
Further information:
http://www.imperial.ac.uk

More articles from Health and Medicine:

nachricht Investigators may unlock mystery of how staph cells dodge the body's immune system
22.09.2017 | Cedars-Sinai Medical Center

nachricht Monitoring the heart's mitochondria to predict cardiac arrest?
21.09.2017 | Boston Children's Hospital

All articles from Health and Medicine >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: The pyrenoid is a carbon-fixing liquid droplet

Plants and algae use the enzyme Rubisco to fix carbon dioxide, removing it from the atmosphere and converting it into biomass. Algae have figured out a way to increase the efficiency of carbon fixation. They gather most of their Rubisco into a ball-shaped microcompartment called the pyrenoid, which they flood with a high local concentration of carbon dioxide. A team of scientists at Princeton University, the Carnegie Institution for Science, Stanford University and the Max Plank Institute of Biochemistry have unravelled the mysteries of how the pyrenoid is assembled. These insights can help to engineer crops that remove more carbon dioxide from the atmosphere while producing more food.

A warming planet

Im Focus: Highly precise wiring in the Cerebral Cortex

Our brains house extremely complex neuronal circuits, whose detailed structures are still largely unknown. This is especially true for the so-called cerebral cortex of mammals, where among other things vision, thoughts or spatial orientation are being computed. Here the rules by which nerve cells are connected to each other are only partly understood. A team of scientists around Moritz Helmstaedter at the Frankfiurt Max Planck Institute for Brain Research and Helene Schmidt (Humboldt University in Berlin) have now discovered a surprisingly precise nerve cell connectivity pattern in the part of the cerebral cortex that is responsible for orienting the individual animal or human in space.

The researchers report online in Nature (Schmidt et al., 2017. Axonal synapse sorting in medial entorhinal cortex, DOI: 10.1038/nature24005) that synapses in...

Im Focus: Tiny lasers from a gallery of whispers

New technique promises tunable laser devices

Whispering gallery mode (WGM) resonators are used to make tiny micro-lasers, sensors, switches, routers and other devices. These tiny structures rely on a...

Im Focus: Ultrafast snapshots of relaxing electrons in solids

Using ultrafast flashes of laser and x-ray radiation, scientists at the Max Planck Institute of Quantum Optics (Garching, Germany) took snapshots of the briefest electron motion inside a solid material to date. The electron motion lasted only 750 billionths of the billionth of a second before it fainted, setting a new record of human capability to capture ultrafast processes inside solids!

When x-rays shine onto solid materials or large molecules, an electron is pushed away from its original place near the nucleus of the atom, leaving a hole...

Im Focus: Quantum Sensors Decipher Magnetic Ordering in a New Semiconducting Material

For the first time, physicists have successfully imaged spiral magnetic ordering in a multiferroic material. These materials are considered highly promising candidates for future data storage media. The researchers were able to prove their findings using unique quantum sensors that were developed at Basel University and that can analyze electromagnetic fields on the nanometer scale. The results – obtained by scientists from the University of Basel’s Department of Physics, the Swiss Nanoscience Institute, the University of Montpellier and several laboratories from University Paris-Saclay – were recently published in the journal Nature.

Multiferroics are materials that simultaneously react to electric and magnetic fields. These two properties are rarely found together, and their combined...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

“Lasers in Composites Symposium” in Aachen – from Science to Application

19.09.2017 | Event News

I-ESA 2018 – Call for Papers

12.09.2017 | Event News

EMBO at Basel Life, a new conference on current and emerging life science research

06.09.2017 | Event News

 
Latest News

Rainbow colors reveal cell history: Uncovering β-cell heterogeneity

22.09.2017 | Life Sciences

Penn first in world to treat patient with new radiation technology

22.09.2017 | Medical Engineering

Calculating quietness

22.09.2017 | Physics and Astronomy

VideoLinks
B2B-VideoLinks
More VideoLinks >>>